Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Who Should Be Cautious Anyone who is pregnant or breastfeeding, unless a clinician specifically approves it
Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells
Despite these promising findings, it is critical to evaluate safety, as there is a significant lack of comprehensive clinical trials to establish the safety or efficacy of BPC-157 in humans
Ddit4 licenses only healthy cells to proliferate during injury-induced metaplasia
US$ 25.97
US$ 21.60
US$ 23.65
US$ 29.68
